Pre-order Enquiry
Request Free Sample
Global Hereditary Angioedema Drug Sales Market Report 2021
SKU ID : QYR-17476345 | Publishing Date : 01-Mar-2021 | No. of pages : 124
Detailed TOC of Global Hereditary Angioedema Drug Sales Market Report 2021
1 Hereditary Angioedema Drug Market Overview1.1 Hereditary Angioedema Drug Product Scope
1.2 Hereditary Angioedema Drug Segment by Type
1.2.1 Global Hereditary Angioedema Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Drug Segment by Application
1.3.1 Global Hereditary Angioedema Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Hereditary Angioedema Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hereditary Angioedema Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hereditary Angioedema Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hereditary Angioedema Drug Price Trends (2016-2027)
2 Hereditary Angioedema Drug Estimates and Forecasts by Region
2.1 Global Hereditary Angioedema Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hereditary Angioedema Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hereditary Angioedema Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Hereditary Angioedema Drug Revenue Market Share by Region (2016-2021)
2.3 Global Hereditary Angioedema Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hereditary Angioedema Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hereditary Angioedema Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hereditary Angioedema Drug Estimates and Projections (2016-2027)
2.4.2 Europe Hereditary Angioedema Drug Estimates and Projections (2016-2027)
2.4.3 China Hereditary Angioedema Drug Estimates and Projections (2016-2027)
2.4.4 Japan Hereditary Angioedema Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hereditary Angioedema Drug Estimates and Projections (2016-2027)
2.4.6 India Hereditary Angioedema Drug Estimates and Projections (2016-2027)
3 Global Hereditary Angioedema Drug Competition Landscape by Players
3.1 Global Top Hereditary Angioedema Drug Players by Sales (2016-2021)
3.2 Global Top Hereditary Angioedema Drug Players by Revenue (2016-2021)
3.3 Global Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2020)
3.4 Global Hereditary Angioedema Drug Average Price by Company (2016-2021)
3.5 Manufacturers Hereditary Angioedema Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hereditary Angioedema Drug Market Size by Type
4.1 Global Hereditary Angioedema Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Hereditary Angioedema Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Hereditary Angioedema Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Hereditary Angioedema Drug Price by Type (2016-2021)
4.2 Global Hereditary Angioedema Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hereditary Angioedema Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Hereditary Angioedema Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Hereditary Angioedema Drug Price Forecast by Type (2022-2027)
5 Global Hereditary Angioedema Drug Market Size by Application
5.1 Global Hereditary Angioedema Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Hereditary Angioedema Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Hereditary Angioedema Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Hereditary Angioedema Drug Price by Application (2016-2021)
5.2 Global Hereditary Angioedema Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hereditary Angioedema Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Hereditary Angioedema Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Hereditary Angioedema Drug Price Forecast by Application (2022-2027)
6 North America Hereditary Angioedema Drug Market Facts & Figures
6.1 North America Hereditary Angioedema Drug Sales by Company
6.1.1 North America Hereditary Angioedema Drug Sales by Company (2016-2021)
6.1.2 North America Hereditary Angioedema Drug Revenue by Company (2016-2021)
6.2 North America Hereditary Angioedema Drug Sales Breakdown by Type
6.2.1 North America Hereditary Angioedema Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Hereditary Angioedema Drug Sales Breakdown by Type (2022-2027)
6.3 North America Hereditary Angioedema Drug Sales Breakdown by Application
6.3.1 North America Hereditary Angioedema Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Hereditary Angioedema Drug Sales Breakdown by Application (2022-2027)
7 Europe Hereditary Angioedema Drug Market Facts & Figures
7.1 Europe Hereditary Angioedema Drug Sales by Company
7.1.1 Europe Hereditary Angioedema Drug Sales by Company (2016-2021)
7.1.2 Europe Hereditary Angioedema Drug Revenue by Company (2016-2021)
7.2 Europe Hereditary Angioedema Drug Sales Breakdown by Type
7.2.1 Europe Hereditary Angioedema Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hereditary Angioedema Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Hereditary Angioedema Drug Sales Breakdown by Application
7.3.1 Europe 124 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 124 Sales Breakdown by Application (2022-2027)
8 China Hereditary Angioedema Drug Market Facts & Figures
8.1 China Hereditary Angioedema Drug Sales by Company
8.1.1 China Hereditary Angioedema Drug Sales by Company (2016-2021)
8.1.2 China Hereditary Angioedema Drug Revenue by Company (2016-2021)
8.2 China Hereditary Angioedema Drug Sales Breakdown by Type
8.2.1 China Hereditary Angioedema Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Hereditary Angioedema Drug Sales Breakdown by Type (2022-2027)
8.3 China Hereditary Angioedema Drug Sales Breakdown by Application
8.3.1 China 142 Sales Breakdown by Application (2016-2021)
8.3.2 China 142 Sales Breakdown by Application (2022-2027)
9 Japan Hereditary Angioedema Drug Market Facts & Figures
9.1 Japan Hereditary Angioedema Drug Sales by Company
9.1.1 Japan Hereditary Angioedema Drug Sales by Company (2016-2021)
9.1.2 Japan Hereditary Angioedema Drug Revenue by Company (2016-2021)
9.2 Japan Hereditary Angioedema Drug Sales Breakdown by Type
9.2.1 Japan Hereditary Angioedema Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hereditary Angioedema Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Hereditary Angioedema Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hereditary Angioedema Drug Market Facts & Figures
10.1 Southeast Asia Hereditary Angioedema Drug Sales by Company
10.1.1 Southeast Asia Hereditary Angioedema Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Hereditary Angioedema Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Hereditary Angioedema Drug Sales Breakdown by Type
10.2.1 Southeast Asia Hereditary Angioedema Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hereditary Angioedema Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hereditary Angioedema Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Hereditary Angioedema Drug Market Facts & Figures
11.1 India Hereditary Angioedema Drug Sales by Company
11.1.1 India Hereditary Angioedema Drug Sales by Company (2016-2021)
11.1.2 India Hereditary Angioedema Drug Revenue by Company (2016-2021)
11.2 India Hereditary Angioedema Drug Sales Breakdown by Type
11.2.1 India Hereditary Angioedema Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Hereditary Angioedema Drug Sales Breakdown by Type (2022-2027)
11.3 India Hereditary Angioedema Drug Sales Breakdown by Application
11.3.1 India Hereditary Angioedema Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Hereditary Angioedema Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hereditary Angioedema Drug Business
12.1 Pharming Group NV
12.1.1 Pharming Group NV Corporation Information
12.1.2 Pharming Group NV Business Overview
12.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pharming Group NV Hereditary Angioedema Drug Products Offered
12.1.5 Pharming Group NV Recent Development
12.2 Takeda
12.2.1 Takeda Corporation Information
12.2.2 Takeda Business Overview
12.2.3 Takeda Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Takeda Hereditary Angioedema Drug Products Offered
12.2.5 Takeda Recent Development
12.3 CSL Limited
12.3.1 CSL Limited Corporation Information
12.3.2 CSL Limited Business Overview
12.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Limited Hereditary Angioedema Drug Products Offered
12.3.5 CSL Limited Recent Development
12.4 IBio Inc.
12.4.1 IBio Inc. Corporation Information
12.4.2 IBio Inc. Business Overview
12.4.3 IBio Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 IBio Inc. Hereditary Angioedema Drug Products Offered
12.4.5 IBio Inc. Recent Development
12.5 BioCryst Pharmaceuticals, Inc.
12.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
12.5.2 BioCryst Pharmaceuticals, Inc. Business Overview
12.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered
12.5.5 BioCryst Pharmaceuticals, Inc. Recent Development
12.6 Ionis Pharmaceuticals, Inc.
12.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
12.6.2 Ionis Pharmaceuticals, Inc. Business Overview
12.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered
12.6.5 Ionis Pharmaceuticals, Inc. Recent Development
...
13 Hereditary Angioedema Drug Manufacturing Cost Analysis
13.1 Hereditary Angioedema Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hereditary Angioedema Drug
13.4 Hereditary Angioedema Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hereditary Angioedema Drug Distributors List
14.3 Hereditary Angioedema Drug Customers
15 Market Dynamics
15.1 Hereditary Angioedema Drug Market Trends
15.2 Hereditary Angioedema Drug Drivers
15.3 Hereditary Angioedema Drug Market Challenges
15.4 Hereditary Angioedema Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Figures, Tables and Charts Available in Global Hereditary Angioedema Drug Sales Market Report 2021
List of TablesTable 1. Global Hereditary Angioedema Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hereditary Angioedema Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hereditary Angioedema Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hereditary Angioedema Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Hereditary Angioedema Drug Sales Market Share by Region (2016-2021)
Table 6. Global Hereditary Angioedema Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hereditary Angioedema Drug Revenue Share by Region (2016-2021)
Table 8. Global Hereditary Angioedema Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Hereditary Angioedema Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hereditary Angioedema Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hereditary Angioedema Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hereditary Angioedema Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Hereditary Angioedema Drug Sales Share by Company (2016-2021)
Table 14. Global Hereditary Angioedema Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hereditary Angioedema Drug Revenue Share by Company (2016-2021)
Table 16. Global Hereditary Angioedema Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Drug as of 2020)
Table 17. Global Hereditary Angioedema Drug Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Hereditary Angioedema Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Hereditary Angioedema Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hereditary Angioedema Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Hereditary Angioedema Drug Sales Share by Type (2016-2021)
Table 23. Global Hereditary Angioedema Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2016-2021)
Table 25. Global Hereditary Angioedema Drug Sales Share by Type (2022-2027)
Table 26. Global Hereditary Angioedema Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hereditary Angioedema Drug Revenue Share by Type (2022-2027)
Table 28. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2022-2027)
Table 29. Global Hereditary Angioedema Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Hereditary Angioedema Drug Sales Share by Application (2016-2021)
Table 31. Global Hereditary Angioedema Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2016-2021)
Table 33. Global Hereditary Angioedema Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Hereditary Angioedema Drug Sales Share by Application (2022-2027)
Table 35. Global Hereditary Angioedema Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hereditary Angioedema Drug Revenue Share by Application (2022-2027)
Table 37. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2022-2027)
Table 38. North America Hereditary Angioedema Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Hereditary Angioedema Drug Sales Market Share by Company (2016-2021)
Table 40. North America Hereditary Angioedema Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hereditary Angioedema Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Hereditary Angioedema Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Hereditary Angioedema Drug Sales Market Share by Type (2016-2021)
Table 44. North America Hereditary Angioedema Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Hereditary Angioedema Drug Sales Market Share by Type (2022-2027)
Table 46. North America Hereditary Angioedema Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Hereditary Angioedema Drug Sales Market Share by Application (2016-2021)
Table 48. North America Hereditary Angioedema Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Hereditary Angioedema Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Hereditary Angioedema Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Hereditary Angioedema Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Hereditary Angioedema Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hereditary Angioedema Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Hereditary Angioedema Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Hereditary Angioedema Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Hereditary Angioedema Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Hereditary Angioedema Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Hereditary Angioedema Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Hereditary Angioedema Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Hereditary Angioedema Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Hereditary Angioedema Drug Sales Market Share by Application (2022-2027)
Table 62. China Hereditary Angioedema Drug Sales (K Units) by Company (2016-2021)
Table 63. China Hereditary Angioedema Drug Sales Market Share by Company (2016-2021)
Table 64. China Hereditary Angioedema Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hereditary Angioedema Drug Revenue Market Share by Company (2016-2021)
Table 66. China Hereditary Angioedema Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Hereditary Angioedema Drug Sales Market Share by Type (2016-2021)
Table 68. China Hereditary Angioedema Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Hereditary Angioedema Drug Sales Market Share by Type (2022-2027)
Table 70. China Hereditary Angioedema Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Hereditary Angioedema Drug Sales Market Share by Application (2016-2021)
Table 72. China Hereditary Angioedema Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Hereditary Angioedema Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Hereditary Angioedema Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Hereditary Angioedema Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Hereditary Angioedema Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hereditary Angioedema Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Hereditary Angioedema Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Hereditary Angioedema Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Hereditary Angioedema Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Hereditary Angioedema Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Hereditary Angioedema Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Hereditary Angioedema Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Hereditary Angioedema Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Hereditary Angioedema Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hereditary Angioedema Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Hereditary Angioedema Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hereditary Angioedema Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hereditary Angioedema Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hereditary Angioedema Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Hereditary Angioedema Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hereditary Angioedema Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Hereditary Angioedema Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hereditary Angioedema Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Hereditary Angioedema Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hereditary Angioedema Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Hereditary Angioedema Drug Sales Market Share by Application (2022-2027)
Table 98. India Hereditary Angioedema Drug Sales (K Units) by Company (2016-2021)
Table 99. India Hereditary Angioedema Drug Sales Market Share by Company (2016-2021)
Table 100. India Hereditary Angioedema Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hereditary Angioedema Drug Revenue Market Share by Company (2016-2021)
Table 102. India Hereditary Angioedema Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Hereditary Angioedema Drug Sales Market Share by Type (2016-2021)
Table 104. India Hereditary Angioedema Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Hereditary Angioedema Drug Sales Market Share by Type (2022-2027)
Table 106. India Hereditary Angioedema Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Hereditary Angioedema Drug Sales Market Share by Application (2016-2021)
Table 108. India Hereditary Angioedema Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Hereditary Angioedema Drug Sales Market Share by Application (2022-2027)
Table 110. Pharming Group NV Corporation Information
Table 111. Pharming Group NV Description and Business Overview
Table 112. Pharming Group NV Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pharming Group NV Hereditary Angioedema Drug Product
Table 114. Pharming Group NV Recent Development
Table 115. Takeda Corporation Information
Table 116. Takeda Description and Business Overview
Table 117. Takeda Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Takeda Hereditary Angioedema Drug Product
Table 119. Takeda Recent Development
Table 120. CSL Limited Corporation Information
Table 121. CSL Limited Description and Business Overview
Table 122. CSL Limited Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. CSL Limited Hereditary Angioedema Drug Product
Table 124. CSL Limited Recent Development
Table 125. IBio Inc. Corporation Information
Table 126. IBio Inc. Description and Business Overview
Table 127. IBio Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. IBio Inc. Hereditary Angioedema Drug Product
Table 129. IBio Inc. Recent Development
Table 130. BioCryst Pharmaceuticals, Inc. Corporation Information
Table 131. BioCryst Pharmaceuticals, Inc. Description and Business Overview
Table 132. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product
Table 134. BioCryst Pharmaceuticals, Inc. Recent Development
Table 135. Ionis Pharmaceuticals, Inc. Corporation Information
Table 136. Ionis Pharmaceuticals, Inc. Description and Business Overview
Table 137. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product
Table 139. Ionis Pharmaceuticals, Inc. Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Hereditary Angioedema Drug Distributors List
Table 143. Hereditary Angioedema Drug Customers List
Table 144. Hereditary Angioedema Drug Market Trends
Table 145. Hereditary Angioedema Drug Market Drivers
Table 146. Hereditary Angioedema Drug Market Challenges
Table 147. Hereditary Angioedema Drug Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Hereditary Angioedema Drug Product Picture
Figure 2. Global Hereditary Angioedema Drug Sales Market Share by Type in 2021 & 2027
Figure 3. C1 Esterase Inhibitor Product Picture
Figure 4. Kallikrein Inhibitor Product Picture
Figure 5. Selective Bradykinin B2 Receptor Antagonist Product Picture
Figure 6. Global Hereditary Angioedema Drug Sales Market Share by Application in 2021 & 2027
Figure 7. Retail Pharmacies Examples
Figure 8. Hospital Pharmacies Examples
Figure 9. Online Pharmacies Examples
Figure 10. Global Hereditary Angioedema Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hereditary Angioedema Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Hereditary Angioedema Drug Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Hereditary Angioedema Drug Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Hereditary Angioedema Drug Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Hereditary Angioedema Drug Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Hereditary Angioedema Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Hereditary Angioedema Drug Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Hereditary Angioedema Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Hereditary Angioedema Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Hereditary Angioedema Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Hereditary Angioedema Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Hereditary Angioedema Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Hereditary Angioedema Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Hereditary Angioedema Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Hereditary Angioedema Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Hereditary Angioedema Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Hereditary Angioedema Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Hereditary Angioedema Drug Players Market Share by Revenue in Hereditary Angioedema Drug: 2016 & 2020
Figure 29. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Hereditary Angioedema Drug Revenue Share by Type (2016-2021)
Figure 31. Global Hereditary Angioedema Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Hereditary Angioedema Drug Revenue Share by Application (2016-2021)
Figure 33. Global Hereditary Angioedema Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Hereditary Angioedema Drug Sales Market Share by Type in 2020
Figure 35. North America Hereditary Angioedema Drug Sales Market Share by Application in 2020
Figure 36. Europe Hereditary Angioedema Drug Sales Market Share by Type in 2020
Figure 37. Europe Hereditary Angioedema Drug Sales Market Share by Application in 2020
Figure 38. China Hereditary Angioedema Drug Sales Market Share by Type in 2020
Figure 39. China Hereditary Angioedema Drug Sales Market Share by Application in 2020
Figure 40. Japan Hereditary Angioedema Drug Sales Market Share by Type in 2020
Figure 41. Japan Hereditary Angioedema Drug Sales Market Share by Application in 2020
Figure 42. Southeast Asia Hereditary Angioedema Drug Sales Market Share by Type in 2020
Figure 43. Southeast Asia Hereditary Angioedema Drug Sales Market Share by Application in 2020
Figure 44. India Hereditary Angioedema Drug Sales Market Share by Type in 2020
Figure 45. India Hereditary Angioedema Drug Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Hereditary Angioedema Drug
Figure 48. Manufacturing Process Analysis of Hereditary Angioedema Drug
Figure 49. Hereditary Angioedema Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Keyplayers in Global Hereditary Angioedema Drug Sales Market Report 2021
Pharming Group NVTakeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Request Sample
Request Discount
